Swaziland: Natural Weapons Put Malaria On Notice - Eco-Friendly Insecticides in Eswatini

[UNEP] Living atop a hill in Malindza, a tiny county in eSwatini's lush east, 56-year-old Ntombi Ndzimandze is the matriarch of her household of 11 women and children.
Source: AllAfrica News: Malaria - Category: Infectious Diseases Source Type: news

Related Links:

Authors: Maharaj R, Kissoon S, Lakan V, Kheswa N Abstract A high-level review was conducted of the literature pertaining to the challenges and opportunities for eliminating malaria on the African continent. Although malaria mortality and morbidity are on the decline, the disease remains one of public health importance. Africa has invariably borne the brunt of the disease, recording the highest number of cases and deaths. However, with greater emphasis being placed on the disease by the international community, partnerships have developed to boost malaria elimination efforts on the continent. One such initiative is ...
Source: South African Medical Journal - Category: African Health Tags: S Afr Med J Source Type: research
Authors: Conti P, Younes A Abstract CoV-19/SARS-CoV-2 is a highly pathogenic virus that causes coronavirus-19 disease (COVID-19) an acute respiratory distress syndrome which provokes serious problems for global health. Studies suggest that there are many differences between men and women in the immune response to CoV-19 infection and inflammatory diseases. Women, compared to men, are less susceptible to viral infections based on a different innate immunity, steroid hormones and factors related to sex chromosomes. The presence of two X chromosomes in women emphasize the immune system even if one is inactive. The imm...
Source: Journal of Biological Regulators and Homeostatic Agents - Category: Biomedical Science Tags: J Biol Regul Homeost Agents Source Type: research
In mid-March, President Donald Trump personally pressed federal health officials to make malaria drugs available to treat the novel coronavirus, though they had been untested for COVID-19, two sources told Reuters.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Infectious Diseases News Source Type: news
Condition:   Malaria Interventions:   Drug: Sulfadoxine-pyrimethamine (SP);   Drug: Dihydroartemisinin-piperaquine (DP) Sponsors:   Grant Dorsey, M.D, Ph.D.;   National Institutes of Health (NIH);   Infectious Diseases Research Collaboration, Uganda Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Trump has touted the anti-malaria drug as a “game-changer” despite a lack of proof that it can cure coronavirus.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Source Type: news
Zororo Makamba wasn’t supposed to die of the novel coronavirus. Not just because of his age, which at 30 placed him well out of the at-risk category for COVID-19 complications, but because of who he was. A well-known, pro-government media personality in Zimbabwe, and the son of a prominent business mogul, Makamba had the wealth and the connections that should have guaranteed him the best care possible. Instead, on March 23, Zimbabwe’s first confirmed case of the coronavirus died alone in a quarantined hospital, three days after his diagnosis. Hospital staff, lacking protective equipment, were afraid to come nea...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 Source Type: news
By Casey Bishopp, Communications officer, IntraHealth International ; Philippe Kayibana, Community health facilitator, IngobyiApril 07, 2020Philippe Kayibanda is a registered nurse with 13 years of experience working to improve Rwanda’s health system. For him, it’s the power of communication that helps nurses meet their own needs while responding to COVID-19 and caring for patients.“I want nurses around the world to improve communication on their teams,” he says.“In order to be successful, we have to communicate our challenges, our experiences, and our lessons.”When Kayibanda became ...
Source: IntraHealth International - Category: International Medicine & Public Health Authors: Tags: Infectious Diseases COVID-19 Education & Performance Leadership and Governance Health Workers Nurses Source Type: news
Condition:   Malaria Interventions:   Drug: Sulfadoxine-pyrimethamine (SP);   Drug: Dihydroartemisinin-piperaquine (DP) Sponsors:   Grant Dorsey, M.D, Ph.D.;   National Institutes of Health (NIH);   Infectious Diseases Research Collaboration, Uganda Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
CONCLUSION: All examined treatments, although potentiality effective against COVID-19, need either appropriate drug development or clinical trial to be suitable for clinical use. PMID: 32251618 [PubMed - as supplied by publisher]
Source: J Pharm Pharm Sci - Category: Drugs & Pharmacology Authors: Tags: J Pharm Pharm Sci Source Type: research
US president called Modi and threatened ‘retaliation’ if country kept full export banCoronavirus – latest updatesSee all our coronavirus coverageIndia has approved some exports ofhydroxychloroquine, an anti-malaria drug being touted as a possible coronavirus treatment, after apparent pressure from Donald Trump, who has been urging Americans to take it.The tablets are used to prevent and treat malaria, lupus and rheumatoid arthritis but over the past week the US president has been aggressively promoting the drug as a treatment for coronavirus, despite there being no conclusive medical evidence to prove its...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: India South and Central Asia World news US news Malaria Coronavirus outbreak Infectious diseases Medical research Science Source Type: news
More News: Children | Infectious Diseases | Malaria | Swaziland Health | Women